Cornercap Investment Counsel Inc. trimmed its stake in shares of John Wiley & Sons, Inc. (NYSE:WLY - Free Report) by 63.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,000 shares of the company's stock after selling 19,339 shares during the quarter. Cornercap Investment Counsel Inc.'s holdings in John Wiley & Sons were worth $531,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Dimensional Fund Advisors LP grew its stake in John Wiley & Sons by 4.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,924,498 shares of the company's stock valued at $78,326,000 after buying an additional 90,693 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of John Wiley & Sons by 1.9% during the second quarter. Bank of New York Mellon Corp now owns 1,302,764 shares of the company's stock worth $53,022,000 after purchasing an additional 24,215 shares during the period. Burgundy Asset Management Ltd. lifted its holdings in John Wiley & Sons by 1.6% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 987,612 shares of the company's stock worth $40,196,000 after purchasing an additional 15,372 shares during the last quarter. Raymond James & Associates boosted its stake in John Wiley & Sons by 19.5% in the 2nd quarter. Raymond James & Associates now owns 501,891 shares of the company's stock valued at $20,427,000 after purchasing an additional 81,968 shares during the period. Finally, Ceredex Value Advisors LLC grew its holdings in John Wiley & Sons by 3.0% in the 2nd quarter. Ceredex Value Advisors LLC now owns 218,299 shares of the company's stock valued at $8,885,000 after buying an additional 6,400 shares in the last quarter. 73.94% of the stock is owned by institutional investors.
John Wiley & Sons Stock Performance
Shares of WLY traded down $1.34 during midday trading on Friday, reaching $51.43. 184,311 shares of the stock were exchanged, compared to its average volume of 261,042. The company has a quick ratio of 0.53, a current ratio of 0.57 and a debt-to-equity ratio of 1.27. The stock's 50 day simple moving average is $48.99 and its 200 day simple moving average is $44.65. John Wiley & Sons, Inc. has a twelve month low of $29.04 and a twelve month high of $53.79. The company has a market cap of $2.79 billion, a P/E ratio of -25.72 and a beta of 0.85.
John Wiley & Sons (NYSE:WLY - Get Free Report) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.47 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.55 by ($0.08). John Wiley & Sons had a negative net margin of 6.00% and a positive return on equity of 21.59%. The business had revenue of $403.81 million during the quarter, compared to the consensus estimate of $387.40 million. During the same period in the prior year, the firm earned $0.27 EPS. The business's revenue for the quarter was down 10.5% on a year-over-year basis.
John Wiley & Sons Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, October 24th. Stockholders of record on Tuesday, October 8th were given a dividend of $0.352 per share. The ex-dividend date was Tuesday, October 8th. This represents a $1.41 dividend on an annualized basis and a dividend yield of 2.74%. John Wiley & Sons's payout ratio is -70.50%.
Insider Transactions at John Wiley & Sons
In other John Wiley & Sons news, EVP Danielle Mcmahan sold 2,318 shares of the firm's stock in a transaction on Tuesday, October 8th. The stock was sold at an average price of $49.41, for a total value of $114,532.38. Following the sale, the executive vice president now owns 8,978 shares of the company's stock, valued at approximately $443,602.98. This trade represents a 20.52 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.62% of the stock is currently owned by insiders.
John Wiley & Sons Company Profile
(
Free Report)
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
Featured Stories
Before you consider John Wiley & Sons, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and John Wiley & Sons wasn't on the list.
While John Wiley & Sons currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.